[Clinical Edge] Rebamipide Eye Drops Sting More Each Time I Use Them. Should I Continue?

 Mild stinging or burning for a short time after using rebamipide eye drops can occur in some patients.

If the discomfort is mild and disappears within a few minutes, you may usually continue using the drops as prescribed. However, if the pain becomes stronger with each dose, lasts for a long time, or is accompanied by worsening redness, swelling, or blurred vision, stop and contact your eye care professional.

Is Brief Stinging After an Eye Drop Normal?

A mild burning, stinging, or gritty sensation immediately after applying an eye drop can occur, especially when the ocular surface is already dry or inflamed.

This type of discomfort is generally less concerning when it:

• Is mild
• Lasts only a few seconds or minutes
• Improves without treatment
• Does not become worse with repeated use
• Is not accompanied by reduced vision or significant redness

In this situation, many patients can continue the medication according to the prescribed schedule.

What If the Stinging Gets Worse With Every Dose?

Increasing discomfort should not simply be ignored.

Possible explanations include:

• Irritation from the medication or its inactive ingredients
• Sensitivity to a preservative
• An allergic reaction
• Worsening dry eye or ocular surface inflammation
• A corneal epithelial defect
• Another eye condition unrelated to the medication

An examination may be necessary to determine whether the symptoms are caused by the drops or by the underlying eye condition.

Warning Signs That Need Medical Advice

Contact your eye clinic if you experience:

• Pain that becomes stronger after each application
• Burning that continues for a prolonged period
• Increasing redness
• Eyelid itching or swelling
• Persistent blurred vision
• Significant light sensitivity
• Discharge from the eye
• A feeling that something is scratching the eye

These symptoms are not typical of simple, brief post-instillation discomfort.

Should You Stop the Drops on Your Own?

That depends on the severity of the reaction.

If the stinging is mild, brief, and stable, you can generally continue the drops and discuss it at your next appointment.

If the discomfort is clearly worsening or is accompanied by redness, swelling, or reduced vision, do not keep applying the medication without seeking advice. Contact the prescribing clinic and ask whether the medication should be paused, replaced, or examined more closely.

Do not restart a medication that caused a suspected allergic reaction unless a clinician has advised you to do so.

When Is Urgent Evaluation Needed?

Seek prompt medical attention if you develop:

• Severe or intolerable eye pain
• Sudden loss or significant reduction of vision
• Marked redness
• Severe light sensitivity
• Swelling of the eyelids or face
• Difficulty breathing
• Widespread hives or another systemic allergic reaction

Severe pain, photophobia, and reduced vision may indicate a corneal problem or another condition that requires urgent evaluation.

Can You Reduce Mild Stinging?

Do not dilute the medication or mix it with another eye drop.

Instead, you can:

• Make sure the bottle tip does not touch your eye or eyelashes
• Use the medication exactly as directed
• Leave at least five minutes between different eye drops
• Ask whether preservative-free artificial tears can be used separately
• Keep the bottle under the storage conditions listed on the label

If the product is a suspension, shake it as instructed before use.

Bottom Line

Brief, mild stinging after using rebamipide eye drops may occur and often settles on its own.

However, if the discomfort becomes worse with repeated use or is accompanied by persistent pain, increasing redness, eyelid swelling, light sensitivity, or blurred vision, contact your eye care professional rather than continuing the medication without evaluation.

Note for international readers: Reva-K® is a South Korean brand containing rebamipide 2% for dry eye–related corneal and conjunctival epithelial damage. Rebamipide ophthalmic products are also used in Japan and certain other Asian markets, but they are not routinely available as approved dry eye medications in many English-speaking countries, including the United States. Brand names, formulations, and approved indications vary by country.